STOCK TITAN
  1. Home
  2. News
  3. PETV

PetVivo Holdings Inc - PETV STOCK NEWS

Welcome to our dedicated news page for PetVivo Holdings (Ticker: PETV), a resource for investors and traders seeking the latest updates and insights on PetVivo Holdings.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PetVivo Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PetVivo Holdings's position in the market.

News
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE SECOND QUARTER ENDED SEPTEMBER 30, 2023
Rhea-AI Summary
PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW) will report financial results on November 14, 2023, after market close. The company will host a conference call to discuss these results at 4:00 p.m. CT (5:00 p.m. ET) on the same day. Attendees can register and access the webcast on PetVivo’s Investor Relations website. A replay of the webcast will be available through the same link. Participants can also access the call using the provided dial-in details.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.93%
Tags
earnings
-
News
PetVivo Holdings, Inc. Announces Scheduled Presentations by PetVivo Veterinarians at the American Association of Equine Practitioners Convention in San Diego, California
Rhea-AI Summary
PetVivo Holdings, Inc. announced that two members of its Scientific/Veterinarian Team will present at the AAEP annual convention. Tom Yarbrough will discuss new classes of joint therapeutics, while Joseph Manning will talk about a novel collagen-elastin hydrogel microparticles biomaterial for joint conditions in equines. The presentations will take place from November 30th to December 2nd, 2023 in San Diego, California.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.18%
Tags
none
-
News
PetVivo Holdings, Inc. Encouraged Over Positive Response Received at 2023 American College of Veterinary Surgeons Conference
Rhea-AI Summary
PetVivo Holdings, Inc. received positive response for its innovative product Spryng™ with OsteoCushion™ technology at the ACVS conference. Two presentations and a clinical study demonstrated the benefits and tolerability of Spryng™ in managing joint-related afflictions in companion animals. The study showed significant improvements in pain, lameness, and quality of life scoring. Spryng™ is a non-invasive alternative for patients with cranial cruciate disease when surgery is not an option.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.63%
Tags
none
News
PetVivo Holdings, Inc. Announces Presentation of Clinical Study Results at the American College of Veterinary Surgeons Conference in Louisville, Kentucky
Rhea-AI Summary
PetVivo Holdings, Inc. to release results of clinical study at ACVS annual conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.31%
Tags
clinical trial
-
News
PetVivo Holdings, Inc. to Exhibit at 2023 American College of Veterinary Surgeons Conference
Rhea-AI Summary
PetVivo Holdings, Inc. to exhibit at ACVS conference and showcase Spryng™ with OsteoCushion™ Technology
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.71%
Tags
none
-
News
PetVivo Holdings Inc. Announces Participation in The ThinkEquity Conference
Rhea-AI Summary
PetVivo Holdings, Inc. to present at The ThinkEquity Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.1%
Tags
none
News
PETVIVO HOLDINGS, INC. ANNOUNCES PARTICIPATION AT THE H.C. WAINWRIGHT GLOBAL INVESTMENT CONFERENCE SEPTEMBER 11-13, 2023
Rhea-AI Summary
PetVivo Holdings, Inc. to present at H.C. Wainwright 25th Annual Global Investment Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.04%
Tags
none
-
News
PetVivo Holdings, Inc. Achieves National Distribution of Spryng to More than 500 Veterinary Clinics in 49 States
Rhea-AI Summary
PetVivo achieves milestone with sale of Spryng to over 500 veterinary clinics in 49 states
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.45%
Tags
none
-
News
PetVivo Recieves Notice of Allowance from United States Patent and Trademark Office for Key Patent Application
Rhea-AI Summary
PetVivo Holdings, Inc. has received a notice of allowance from the USPTO for a patent application related to its biocompatible protein-based particles. The patent provides comprehensive coverage for a range of proprietary products, including the sponge-like particles used in PetVivo's signature product, Spryng™ with OsteoCushion™ Technology. PetVivo's intellectual property portfolio now consists of twenty allowed patents, with ten being United States patents.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.03%
Tags
none
News
PetVivo Reports First Quarter of Fiscal 2024 Financial Results
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.24%
Tags
earnings
Stock PETV logo
PetVivo Holdings Inc

Nasdaq:PETV

PETV Rankings

N/A Ranked by Market Cap
#4423 Ranked by Stock Gains
N/A Ranked by Dividends

PETV Stock Data

16.25M
11.85M
37.54%
4.86%
0.77%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States
Minneapolis

About PETV

petvivo, inc is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics. petvivo believes that it can leverage the investments in the human biomaterials and medical device industries to commercialize therapeutics to pets in a capital and time efficient way. petvivo's strategy is to in-license proprietary products from human medical device companies specifically for use in pets. petvivo, inc, gel-del technologies, inc. and cosmetalife a corporation are all wholly-owned subsidiaries of petvivo holdings, inc.